FDA Adverse Event Injury Summary report: N

POWERWIRE RADIOFREQUENCY GUIDEWIRE

MDR report key: 8593730 · Received May 8, 2019

Report

Report Number
9710452-2019-00012
Event Type
Injury
Date Received
May 8, 2019
Report Date
May 8, 2019
Manufacturer
BAYLIS MEDICAL COMPANY INC.
Product Code
PDU
PMA / PMN Number
K101615
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

THERE IS NO EVIDENCE TO SUGGEST THAT THE BAYLIS MEDICAL DEVICE CAUSED OR CONTRIBUTED TO THE REPORTED INCIDENT. HOWEVER, AS THE BAYLIS MEDICAL DEVICE WAS REPORTED TO BE AMONG THE DEVICES USED IN THE PROCEDURE, BAYLIS MEDICAL HAS DECIDED TO SUBMIT THIS REPORT. THERE IS NO SUSPECTED DEVICE FAILURE. THE REPORTED PATIENT COMPLICATION IS AN INHERENT RISK IN THIS TYPE OF PROCEDURE.

Description of Event or Problem · 1

THE FOLLOWING INCIDENT WAS IDENTIFIED IN A SCIENTIFIC ARTICLE: KELLER, ERIC J., ET AL. "SINGLE-CENTER RETROSPECTIVE REVIEW OF RADIOFREQUENCY WIRE RECANALIZATION OF REFRACTORY CENTRAL VENOUS OCCLUSIONS." JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY 29.11 (2018): 1571-1577. THE POWERWIRE RADIOFREQUENCY GUIDEWIRE WAS USED IN A PROCEDURE FOR RECANALIZATION OF A CENTRAL VENOUS OCCLUSION (CVO). FOLLOWING APPARENT CVO TRAVERSAL, VENOGRAPHY REVEALED WIRE AND CATHETER ENTRY INTO THE PERICARDIAL SPACE. THIS WAS SUCCESSFULLY MANAGED CONSERVATIVELY WITH ANTICOAGULATION REVERSAL, OVERNIGHT OBSERVATION, AND ORAL ANTI-INFLAMMATORY THERAPY FOR PROCEDURE-INDUCED PERICARDITIS, WITH NO LONG-TERM DETRIMENTAL EFFECTS, BUT FURTHER INTERVENTION WAS ABORTED. THERE IS NO EVIDENCE TO SUGGEST THAT THE BAYLIS MEDICAL DEVICE CAUSED OR CONTRIBUTED TO THE REPORTED INCIDENT. HOWEVER, AS THE BAYLIS MEDICAL DEVICE WAS REPORTED TO BE AMONG THE DEVICES USED IN THE PROCEDURE, BAYLIS MEDICAL HAS DECIDED TO SUBMIT THIS REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
387039 POWERWIRE RADIOFREQUENCY GUIDEWIRE PERCUTANEOUS CATHETER PDU BAYLIS MEDICAL COMPANY INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention